FDA awards $25.7M for Sentinel System extension, enhancing health data analysis and website operations

Contract Overview

Contract Amount: $25,692,680 ($25.7M)

Contractor: Harvard Pilgrim Health Care Inc

Awarding Agency: Department of Health and Human Services

Start Date: 2024-09-20

End Date: 2026-09-29

Contract Duration: 739 days

Daily Burn Rate: $34.8K/day

Competition Type: FULL AND OPEN COMPETITION

Pricing Type: FIRM FIXED PRICE

Sector: Healthcare

Official Description: SENTINEL SYSTEM EXTENSION OF SERVICES FOR 1) ARIA SYSTEM, 2) RWE CLAIMS-EHR LINKED DATA, 3) PROGRAM/PROJECT MANAGEMENT, 4) FOLLOW ON TO THE PDUFA VII ASSESSMENT REPORT, 5) WEBSITE OPERATIONS AND MAINTENANCE, 6) TRAINING, 7) SENTINEL ANNUAL WORKSHOP S

Place of Performance

Location: WELLESLEY HILLS, NORFOLK County, MASSACHUSETTS, 02481

State: Massachusetts Government Spending

Plain-Language Summary

Department of Health and Human Services obligated $25.7 million to HARVARD PILGRIM HEALTH CARE INC for work described as: SENTINEL SYSTEM EXTENSION OF SERVICES FOR 1) ARIA SYSTEM, 2) RWE CLAIMS-EHR LINKED DATA, 3) PROGRAM/PROJECT MANAGEMENT, 4) FOLLOW ON TO THE PDUFA VII ASSESSMENT REPORT, 5) WEBSITE OPERATIONS AND MAINTENANCE, 6) TRAINING, 7) SENTINEL ANNUAL WORKSHOP S Key points: 1. Contract focuses on critical health data linkage and system maintenance, supporting public health surveillance. 2. Value appears reasonable given the scope of data integration and system support required. 3. Competition was full and open, suggesting a competitive pricing environment. 4. Performance risk is moderate, given the established nature of the Sentinel system. 5. This contract positions the FDA to continue leveraging advanced data analytics for drug safety. 6. The duration of nearly two years indicates a sustained need for these services.

Value Assessment

Rating: good

The contract's value of $25.7 million over approximately two years for extending the Sentinel System services appears reasonable. This system is crucial for post-market drug surveillance, linking claims and EHR data. While direct comparisons are difficult without specific service breakdowns, the cost aligns with the complexity of managing large-scale health data infrastructure and analytical support. The firm-fixed-price structure provides cost certainty for the government.

Cost Per Unit: N/A

Competition Analysis

Competition Level: full-and-open

The contract was awarded under full and open competition, indicating that multiple vendors had the opportunity to bid. This approach typically fosters a competitive environment, driving down prices and encouraging innovation. The specific number of bidders is not provided, but the open competition suggests that the government sought the best value from a wide range of qualified providers.

Taxpayer Impact: Full and open competition is beneficial for taxpayers as it increases the likelihood of securing services at competitive market rates, preventing potential overspending and ensuring efficient use of public funds.

Public Impact

The Food and Drug Administration (FDA) benefits directly through enhanced capabilities for its Sentinel System. The public benefits from improved drug safety surveillance and faster identification of potential health risks associated with medications. Services delivered include data linkage, system maintenance, website operations, and program management, all critical for public health. The geographic impact is national, as the Sentinel System's findings inform regulatory decisions affecting all US citizens. Workforce implications include support for researchers, data scientists, and IT professionals involved in pharmacovigilance.

Waste & Efficiency Indicators

Waste Risk Score: 50 / 10

Warning Flags

Potential for scope creep if additional data sources or analytical requirements emerge beyond the current contract.
Reliance on a single contractor for critical system extension could pose a risk if performance issues arise.
Ensuring data privacy and security protocols are rigorously maintained throughout the contract period is paramount.

Positive Signals

The contract leverages an established system (Sentinel), reducing initial setup risks and learning curves.
Full and open competition suggests a robust market exists for these specialized services.
The firm-fixed-price contract provides budget predictability for the agency.

Sector Analysis

The Sentinel System operates within the health IT and data analytics sector, specifically focusing on pharmacovigilance and public health surveillance. This sector is characterized by significant investment in data infrastructure, advanced analytics, and regulatory compliance. The market includes specialized firms capable of handling large, sensitive health datasets. Comparable spending benchmarks in this area often involve multi-million dollar contracts for data management, system integration, and analytical support for government health agencies.

Small Business Impact

This contract was awarded under full and open competition and does not appear to have specific small business set-aside provisions. While the prime contractor is Harvard Pilgrim Health Care Inc., a large entity, there may be opportunities for small businesses to participate as subcontractors. The extent of small business subcontracting will depend on the prime contractor's strategy and the specific needs of the services provided.

Oversight & Accountability

Oversight for this contract will likely be managed by the Food and Drug Administration (FDA) contracting officers and program managers. The firm-fixed-price nature of the contract provides a degree of accountability for the contractor to deliver specified services within the agreed budget. Transparency is generally maintained through contract award notices and public reporting, though detailed performance metrics may be internal. The FDA's Office of the Inspector General may conduct audits or investigations if concerns arise.

Related Government Programs

FDA Sentinel Initiative
Drug Safety and Risk Management
Electronic Health Records (EHR) Data Analysis
Claims Data Analysis
Public Health Surveillance Systems
PDUFA VII Program

Risk Flags

Data Security and Privacy
System Integration Complexity
Timeliness of Analytical Deliverables
Reliance on Established Infrastructure

Frequently Asked Questions

What is this federal contract paying for?

Department of Health and Human Services awarded $25.7 million to HARVARD PILGRIM HEALTH CARE INC. SENTINEL SYSTEM EXTENSION OF SERVICES FOR 1) ARIA SYSTEM, 2) RWE CLAIMS-EHR LINKED DATA, 3) PROGRAM/PROJECT MANAGEMENT, 4) FOLLOW ON TO THE PDUFA VII ASSESSMENT REPORT, 5) WEBSITE OPERATIONS AND MAINTENANCE, 6) TRAINING, 7) SENTINEL ANNUAL WORKSHOP S

Who is the contractor on this award?

The obligated recipient is HARVARD PILGRIM HEALTH CARE INC.

Which agency awarded this contract?

Awarding agency: Department of Health and Human Services (Food and Drug Administration).

What is the total obligated amount?

The obligated amount is $25.7 million.

What is the period of performance?

Start: 2024-09-20. End: 2026-09-29.

What is the historical spending trend for the Sentinel System or similar FDA data analysis contracts?

Historical spending on the FDA's Sentinel System and related data analysis initiatives has been substantial, reflecting the critical nature of post-market drug surveillance. While specific figures for prior Sentinel extensions are not detailed here, the program has consistently required significant investment to manage and analyze vast amounts of healthcare data. The current award of $25.7 million for a roughly two-year extension is in line with the ongoing operational and developmental costs associated with maintaining such a complex system. Previous awards for Sentinel-related activities have also been in the multi-million dollar range annually, supporting its evolution and expansion. Understanding the full historical context would require examining annual appropriations and specific contract awards over the past decade.

How does the pricing of this contract compare to industry benchmarks for similar data processing and web hosting services?

Benchmarking the pricing for this contract against general industry standards for data processing and web hosting is challenging due to the specialized nature of the Sentinel System. This contract involves not just standard IT services but also complex health data integration, linkage (claims-EHR), and advanced analytical support for regulatory purposes. While raw data processing and hosting costs can be benchmarked, the value here includes significant intellectual capital, regulatory expertise, and the management of sensitive patient data. Given the specialized requirements and the scale of operations, the $25.7 million award over approximately two years suggests a competitive price point for the unique capabilities provided, rather than a simple commodity service.

What are the primary performance risks associated with extending the Sentinel System services?

The primary performance risks associated with extending the Sentinel System services revolve around data integrity, system availability, and the timely delivery of analytical insights. Ensuring the continuous and accurate linkage of diverse data sources (claims, EHR) is technically complex and prone to errors if not managed meticulously. System downtime or performance degradation could impede critical drug safety monitoring. Furthermore, the ability of the contractor to provide actionable intelligence from the data within required timeframes is crucial for regulatory decision-making. Mitigating these risks involves robust quality assurance processes, clear performance metrics, and strong government oversight to ensure the contractor meets all contractual obligations.

How effective has the Sentinel System been in identifying drug safety signals in the past?

The Sentinel System has demonstrated considerable effectiveness in identifying drug safety signals and informing regulatory actions. It has been instrumental in analyzing real-world evidence from large, diverse patient populations, complementing traditional clinical trial data. For instance, it has been used to investigate potential safety concerns related to various medications, including opioid use, cardiovascular events, and adverse events following vaccination. Its ability to rapidly query large datasets allows the FDA to proactively monitor drug safety trends and respond to emerging issues more efficiently than traditional methods alone. The system's ongoing development and extensions, like this contract, underscore its perceived value and effectiveness in enhancing public health protection.

What is the track record of Harvard Pilgrim Health Care Inc. in performing similar government contracts?

Harvard Pilgrim Health Care Inc. (now part of Point32Health) has a significant track record in managing large-scale health data and providing health services, primarily within the insurance and healthcare provider space. While their direct experience as a prime contractor for complex federal IT and data analytics systems like the Sentinel extension may vary, their core competencies in data management, population health, and healthcare operations are highly relevant. Government contract databases would provide specific details on their past performance, including awards, past performance ratings, and any issues encountered. Their established presence in the healthcare sector suggests a foundational capability to handle the requirements of this contract, though specific federal IT project execution experience would be a key factor.

What are the implications of the PDUFA VII Assessment Report follow-on for this contract?

The inclusion of 'FOLLOW ON TO THE PDUFA VII ASSESSMENT REPORT' indicates that this contract supports activities directly related to the implementation or continuation of recommendations and findings from the Prescription Drug User Fee Act (PDUFA) VII program's assessment. PDUFA reauthorizations often include provisions for enhancing FDA's capabilities, including post-market surveillance and real-world evidence generation. This specific task likely involves leveraging the Sentinel System to fulfill objectives outlined in the PDUFA VII assessment, potentially focusing on specific therapeutic areas, data standards, or analytical methodologies recommended during that period. It signifies a direct link between this contract and broader legislative mandates aimed at improving drug safety oversight.

Industry Classification

NAICS: Information › Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services › Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services

Product/Service Code: SPECIAL STUDIES/ANALYSIS, NOT R&D › SPECIAL STUDIES - NOT R and D

Competition & Pricing

Extent Competed: FULL AND OPEN COMPETITION

Solicitation Procedures: NEGOTIATED PROPOSAL/QUOTE

Pricing Type: FIRM FIXED PRICE (J)

Evaluated Preference: NONE

Contractor Details

Address: 93 WORCESTER ST, WELLESLEY, MA, 02481

Business Categories: Category Business, Corporate Entity Tax Exempt, Nonprofit Organization, Not Designated a Small Business, Special Designations, U.S.-Owned Business

Financial Breakdown

Contract Ceiling: $25,692,680

Exercised Options: $25,692,680

Current Obligation: $25,692,680

Actual Outlays: $24,058,128

Contract Characteristics

Commercial Item: COMMERCIAL PRODUCTS/SERVICES PROCEDURES NOT USED

Cost or Pricing Data: NO

Parent Contract

Parent Award PIID: 75F40119D10037

IDV Type: IDC

Timeline